Dr. Michele Carbone is a renowned researcher, director of Thoracic Oncology and Full Member of the Cancer Biology Program at the University of Hawaiʻi Cancer Center. He holds academic appointments as a Professor (Researcher) at the University of Hawaiʻi Cancer Center and Professor of the Department of Pathology at the John A. Burns School of Medicine, University of Hawaiʻi at Mānoa. He is also the William & Ellen Melohn Chair in Cancer Biology.

Dr. Carbone has received several medical degrees and certifications, including an MD and PhD from Medical School of Rome "La Sapienza" in Italy, Medical Board Certifications in Anatomic Pathology from the University of Rome and University of Chicago. He has received numerous honors and awards for his research, including the 2018 iMiG Wagner Medal, the 2018 PAIR (Prize in American-Italian Relations) in Technical and Technological Science, and the 2014 Mesothelioma Applied Research Foundation-Pioneer Award.

Dr. Carbone's research focuses on investigating the causes of mesothelioma epidemics, specifically the inherited genetic susceptibility to carcinogenic mineral fibers present in the environment and the discovery of inherited mutations of the BRCA1-associated protein 1 (BAP1) that causes mesothelioma and other environmentally-related cancers. He also specializes in pleural pathology and mesothelioma and is board-certified in Anatomic Pathology in Italy and the U.S.